Table 4.
Characteristics of METABRIC TNBC patients.
| Characteristic | TNBC patients (n = 199) | CD8 T cells (0.25 * sd) | T cells gamma delta (0.25 * sd) | ||||
|---|---|---|---|---|---|---|---|
| High CD8 T cells (n = 65) | Low CD8 T cells (n = 101) | p | High T cells gamma delta (n = 66) | Low T cells gamma delta (n = 103) | p | ||
| Mean age at pathologic diagnosis | 53.9 | 53.6 | 54.7 | 0.77* | 53.0 | 54.2 | 0.75* |
| Tumor stage | 0.96# | 0.93# | |||||
| I–II | 129 (65%) | 42 (65%) | 67 (66%) | Y | 44 (67%) | 65 (63%) | Y |
| III–IV | 12 (6%) | 4 (6%) | 7 (7%) | Y | 4 (6%) | 6 (6%) | Y |
| NA | 58 (29%) | 19 (29%) | 27 (27%) | Y | 18 (27%) | 32 (31%) | Y |
| Inferred menopause | 0.87# | 0.97# | |||||
| Pre | 82 (41%) | 28 (43%) | 42 (42%) | Y | 27 (41%) | 43 (42%) | Y |
| Post | 117 (59%) | 37 (57%) | 59 (58%) | Y | 39 (59%) | 60 (58%) | Y |
METABRIC: Molecular Taxonomy of Breast Cancer International Consortium; TNBC: triple negative breast cancer; p: pvalue; sd: standard deviation; *: Wilcoxon test; #: Fisher’s exact test; Y: Used in Fisher’s exact test; N: Not used for Fisher’s exact test; NA: missing data.